Standard curve
Example of NIBSC (93/722) standard curve in Assay Diluent #12.
Product Details
Product Details
Product Specification
Antigen | IL-10 |
Immunogen | Recombinant Protein |
Antibody Type | Recombinant mAb |
Reactivity | Hu |
Purification | Protein A |
Stability & Storage | 2 to 8 °C as supplied. |
Kit
Precision | Intra-assay: 2.9%; Inter-assay:5.6% |
Sample type | Cell culture supernatant, Serum, Plasma |
Assay type | Sandwich (quantitative) |
Sensitivity | 4.013pg/ml |
Range | 9.38 pg/mL – 600 pg/mL |
Recovery | Cell culture supernatant: 101% Serum: 81% Plasma:85% |
Assay time | 60 minutes |
Species reactivity | Human |
NIBSC convert | The dose response curve of the International Standard (93/722) parallels the OneStep standard curve. To convert sample values obtained with the kit to approximate NIBSC (93/722) units, use the following equation: NIBSC (93/722) approximate value (IU/mL) = 0.005 x OneStep Human IL-10 value (pg/mL). |
Picture
Picture
ELISA
Standard curve
Example of human IL-10 standard curve in Assay Diluent #12.
Linearity
The concentrations of Human IL-10 were measured and interpolated from the target standard curves and corrected for sample dilution.
The sample is undiluted samples are as follows: human PBMC cells stimulated with 10ug/ml PHA for 2days (25%). The interpolated dilution factor corrected values are plotted. The mean target concentration was determined to be 4895 pg/mL in stimulated human PBMC supernatant.
Linearity
The sample is undiluted samples are as follows: human PBMC cells culture for 2days (100%). The interpolated dilution factor corrected values are plotted. The mean target concentration was determined to be 58.81pg/mL in unstimulated human PBMC supernatant.
To assess the linearity of the assay, three samples were spiked with high concentrations of Human IL-10 in various matrices and diluted with the appropriate Calibrator Diluent to produce samples with values within the dynamic range of the assay.
Leading Competitor comparison
Protocol Diagram
